Vinapharm CEO awarded as Master Entrepreneur 2024

Vinapharm CEO awarded as Master Entrepreneur 2024

On October 3, Han Thi Khanh Vinh, member of the Board of Directors and CEO of Vietnam Pharmaceutical Corporation (Vinapharm), was honoured with a Master Entrepreneur Award at the Asia Pacific Enterprise Awards (APEA) 2024.
Competition within ASEAN for pharma investment

Competition within ASEAN for pharma investment

With an ageing population, rising disease burden, and advancements in healthcare science, the global pharmaceutical market has seen significant growth in recent years. In 2023, the total market was estimated at $1.6 trillion, an increase in over $100 billion compared to 2022. As one of the largest and fastest-growing industries, the sector drives healthcare innovation globally.
Pharma to experience robust growth

Pharma to experience robust growth

Vietnam healthcare market size is estimated to reach $23.7 billion and grow at an average rate of 7.5 per cent annually from 2023 to 2028. Healthcare expenditure per capita is also projected to increase from $237 to $328 in that time.
Vietnam's pharmaceutical market boasts immense potential

Vietnam's pharmaceutical market boasts immense potential

Vietnam has among the highest pharmaceutical industry growth rates worldwide.
Imexpharm announces interim results for H1

Imexpharm announces interim results for H1

Imexpharm Corporation has announced its interim results for the first six months of 2024.
Promoting Vietnamese pharmaceutical industry

Promoting Vietnamese pharmaceutical industry

The Vietnamese pharmaceutical industry is seeing great advantages.
Imexpharm honoured with Vietnam Pharmaceutical Star award

Imexpharm honoured with Vietnam Pharmaceutical Star award

Imexpharm Pharmaceutical JSC proudly received the “Vietnam Pharmaceutical Star” award for the second time today.
Outlook for pharmaceutical stocks in 2024

Outlook for pharmaceutical stocks in 2024

At a macro level in which there is still complexity, the pharmaceutical industry is expected to continue witnessing positive business results in 2024.
Imexpharm set growth record in 2023

Imexpharm set growth record in 2023

Imexpharm Corporation announced its business results on March 27, for the fiscal year ending December 31, 2023.
Pharmaceutical industry must be managed under market rules: Deputy PM

Pharmaceutical industry must be managed under market rules: Deputy PM

Deputy Prime Minister Tran Hong Ha underlined the need to manage the pharmaceutical industry under market rules, ensuring publicity, transparency, quality control, safety, and cheapest prices during a meeting in Hanoi on February 19 to discuss the law on amendments and supplementations to some articles of the Law on Pharmacy.
The game-changers in pharmaceuticals

The game-changers in pharmaceuticals

Innovative pharmaceuticals are emerging as a game-changer in reshaping the industry.
Legal reform can be key to pharma innovation bonanza

Legal reform can be key to pharma innovation bonanza

As countries are in the race to latch onto new investment from the innovative pharma industry, Vietnam is being urged to improve its legal system to increase its competitiveness.
Pfizer seeks to boost presence in Vietnam

Pfizer seeks to boost presence in Vietnam

A business mission led by Anil Argilla, president of Emerging Markets Asia at Pfizer, worked with Deputy Minister of Health Do Xuan Tuyen on May 25.
The state of play in healthcare M&As

The state of play in healthcare M&As

Merger and acquisition moves are one of the more effective measures for foreign investors entering the Vietnamese medical and pharmaceutical industry, utilising available factories and inexpensive labour. Ngo Thanh Hai, Nguyen Dieu Quynh, and Le Anh Thu from LNT & Partners offers an overview of the factors and barriers involved when it comes to dealmaking in pharma.
Vietnamese, Indian pharmaceutical firms have great opportunities in Vietnam

Vietnamese, Indian pharmaceutical firms have great opportunities in Vietnam

Experts have pointed out lots of opportunities for Vietnamese and Indian enterprises in the pharmaceutical industry in Vietnam.
1 2